We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-0.87%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$369B
AUM Growth
-$12.6B
(-3.3%)
Cap. Flow
+$3.24B
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
31.8%
Holding
3,300
New
48
Increased
1,756
Reduced
1,134
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.25B |
| 2 |
NXUS
Nuveen International Aggregate Bond ETF
NXUS
|
+$938M |
| 3 |
Apple
AAPL
|
+$911M |
| 4 |
Costco
COST
|
+$878M |
| 5 |
NVIDIA
NVDA
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.69B |
| 2 |
ServiceNow
NOW
|
+$651M |
| 3 |
Applied Materials
AMAT
|
+$563M |
| 4 |
Visa
V
|
+$536M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$523M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.9% |
| 2 | Financials | 11.41% |
| 3 | Consumer Discretionary | 10.18% |
| 4 | Industrials | 9.65% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Voyager Therapeutics
VYGR
$187M
| $452K | ﹤0.01% |
117,100
+23,939
| +26% | +$94.2K |
|
2852
Xperi
XPER
$358M
| $450K | ﹤0.01% |
80,326
+524
| +0.7% | +$3.03K |
|
2853
BayCom
BCML
$361M
| $449K | ﹤0.01% |
15,107
-2,444
| -14% | -$71.9K |
|
|
CMRC
2854
Commerce.com Inc Series 1
CMRC
$215M
| $449K | ﹤0.01% |
168,102
+36,639
| +28% | +$114K |
|
2855
Organogenesis Holdings
ORGO
$313M
| $447K | ﹤0.01% |
188,745
-85,230
| -31% | -$295K |
|
2856
Benitec Biopharma
BNTC
$393M
| $445K | ﹤0.01% |
41,814
+23,035
| +123% | +$267K |
|
2857
Maui Land & Pineapple Co
MLP
$339M
| $444K | ﹤0.01% |
28,866
+314
| +1% | +$5.2K |
|
|
FRMI
2858
Fermi Inc
FRMI
$4.03B
| $444K | ﹤0.01% |
75,957
-1,307,479
| -95% | -$11.4M |
|
2859
RCI Hospitality Holdings
RICK
$198M
| $443K | ﹤0.01% |
19,405
-3,089
| -14% | -$72.8K |
|
2860
Aclaris Therapeutics
ACRS
$765M
| $443K | ﹤0.01% |
118,020
-119,810
| -50% | -$404K |
|
2861
Replimune Group
REPL
$878M
| $441K | ﹤0.01% |
57,614
| – | – |
|
2862
Climb Global Solutions
CLMB
$467M
| $440K | ﹤0.01% |
22,212
| – | – |
|
2863
Citizens Financial Services
CZFS
$344M
| $440K | ﹤0.01% |
7,199
| – | – |
|
|
AKTS
2864
Aktis Oncology
AKTS
$1.33B
| $438K | ﹤0.01% |
+24,468
| New | +$475K |
|
2865
RxSight
RXST
$222M
| $437K | ﹤0.01% |
70,887
-460,843
| -87% | -$3.83M |
|
2866
Universal Logistics Holdings
ULH
$435M
| $435K | ﹤0.01% |
20,558
+122
| +0.6% | +$2.09K |
|
2867
Paysign
PAYS
$469M
| $434K | ﹤0.01% |
73,501
+28,491
| +63% | +$115K |
|
|
BLDP
2868
Ballard Power Systems
BLDP
$898M
| $434K | ﹤0.01% |
180,638
| – | – |
|
2869
Nathan's Famous
NATH
$402M
| $433K | ﹤0.01% |
4,295
| – | – |
|
|
PML
2870
PIMCO Municipal Income Fund II
PML
$484M
| $432K | ﹤0.01% |
57,063
+2,000
| +4% | +$15.3K |
|
|
XIFR
2871
XPLR Infrastructure LP
XIFR
$1.18B
| $432K | ﹤0.01% |
40,651
+10,130
| +33% | +$104K |
|
2872
Pure Cycle
PCYO
$255M
| $430K | ﹤0.01% |
42,756
-25,033
| -37% | -$271K |
|
|
RC
2873
Ready Capital
RC
$267M
| $428K | ﹤0.01% |
263,899
-25,308
| -9% | -$48.4K |
|
2874
KRONOS Worldwide
KRO
$764M
| $427K | ﹤0.01% |
65,020
+502
| +0.8% | +$2.85K |
|
2875
8x8 Inc
EGHT
$228M
| $424K | ﹤0.01% |
255,156
+1,347
| +0.5% | +$2.76K |
|
Similar funds
VFT
Nuveen's Q1 2026 Portfolio in Review
As of Q1 2026, Nuveen held 3,300 positions worth $369B, down 3.3% from $382B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 3.8%. Nuveen opened 48 new positions and exited 76, leaving the 3,300-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q1 2026 buy was Sunbelt Rentals Holdings: 2,483,995 shares worth $156M.
- Nuveen added most to AstraZeneca in Q1 2026, an estimated $1.25B increase.
- Nuveen's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.69B.
- Nuveen fully exited Exact Sciences in Q1 2026, selling an estimated $82.6M.
- Nuveen's ten largest holdings make up 32% of its $369B portfolio in Q1 2026.
- Nuveen opened 48 new positions and closed 76 in Q1 2026.
- Nuveen's portfolio value fell 3.3% quarter-over-quarter to $369B.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.